Literature DB >> 20345896

Plasma BDNF concentration, Val66Met genetic variant and depression-related personality traits.

A Terracciano1, B Martin, D Ansari, T Tanaka, L Ferrucci, S Maudsley, M P Mattson, P T Costa.   

Abstract

Brain-derived neurotrophic factor (BDNF) regulates synaptic plasticity and neurogenesis, and BDNF plasma and serum levels have been associated with depression, Alzheimer's disease, and other psychiatric and neurodegenerative disorders. In a relatively large community sample, drawn from the Baltimore Longitudinal Study of Aging (BLSA), we examine whether BDNF plasma concentration is associated with the Val66Met functional polymorphism of the BDNF gene (n = 335) and with depression-related personality traits assessed with the NEO-PI-R (n = 391). Plasma concentration of BDNF was not associated with the Val66Met variant in either men or women. However, in men, but not in women, BDNF plasma level was associated with personality traits linked to depression. Contrary to the notion that low BDNF is associated with negative outcomes, we found lower plasma levels in men who score lower on depression and vulnerability to stress (two facets of Neuroticism) and higher on Conscientiousness and Extraversion. These findings challenge the prevailing hypothesis that lower peripheral levels of BDNF are a marker of depression.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20345896      PMCID: PMC2907437          DOI: 10.1111/j.1601-183X.2010.00579.x

Source DB:  PubMed          Journal:  Genes Brain Behav        ISSN: 1601-183X            Impact factor:   3.449


  64 in total

1.  Impact of reduced meal frequency without caloric restriction on glucose regulation in healthy, normal-weight middle-aged men and women.

Authors:  Olga Carlson; Bronwen Martin; Kim S Stote; Erin Golden; Stuart Maudsley; Samer S Najjar; Luigi Ferrucci; Donald K Ingram; Dan L Longo; William V Rumpler; David J Baer; Josephine Egan; Mark P Mattson
Journal:  Metabolism       Date:  2007-12       Impact factor: 8.694

2.  Plasma brain-derived neurotrophic factor as a peripheral marker for the action mechanism of antidepressants.

Authors:  Hwa-Young Lee; Yong-Ku Kim
Journal:  Neuropsychobiology       Date:  2008-08-05       Impact factor: 2.328

3.  Diurnal variation of plasma brain-derived neurotrophic factor (BDNF) in humans: an analysis of sex differences.

Authors:  Armando Piccinni; Donatella Marazziti; Alessandro Del Debbio; Carolina Bianchi; Isabella Roncaglia; Claudio Mannari; Nicola Origlia; Mario Catena Dell'Osso; Gabriele Massimetti; Luciano Domenici; Liliana Dell'Osso
Journal:  Chronobiol Int       Date:  2008-09       Impact factor: 2.877

4.  BDNF is a novel marker of cognitive function in ageing women: the DR's EXTRA Study.

Authors:  Pirjo Komulainen; Maria Pedersen; Tuomo Hänninen; Helle Bruunsgaard; Timo A Lakka; Miia Kivipelto; Maija Hassinen; Tuomas H Rauramaa; Bente K Pedersen; Rainer Rauramaa
Journal:  Neurobiol Learn Mem       Date:  2008-09-06       Impact factor: 2.877

5.  Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications.

Authors:  Srijan Sen; Ronald Duman; Gerard Sanacora
Journal:  Biol Psychiatry       Date:  2008-06-24       Impact factor: 13.382

6.  Personality predictors of longevity: activity, emotional stability, and conscientiousness.

Authors:  Antonio Terracciano; Corinna E Löckenhoff; Alan B Zonderman; Luigi Ferrucci; Paul T Costa
Journal:  Psychosom Med       Date:  2008-07-02       Impact factor: 4.312

7.  Plasma and serum brain-derived neurotrophic factor (BDNF) in depressed patients during 1 year of antidepressant treatments.

Authors:  Armando Piccinni; Donatella Marazziti; Mario Catena; Luciano Domenici; Alessandro Del Debbio; Carolina Bianchi; Claudio Mannari; Claudia Martini; Eleonora Da Pozzo; Elisa Schiavi; Alessandra Mariotti; Isabella Roncaglia; Agnese Palla; Giorgio Consoli; Luca Giovannini; Gabriele Massimetti; Liliana Dell'Osso
Journal:  J Affect Disord       Date:  2007-06-05       Impact factor: 4.839

Review 8.  BDNF gene: functional Val66Met polymorphism in mood disorders and schizophrenia.

Authors:  Janusz K Rybakowski
Journal:  Pharmacogenomics       Date:  2008-11       Impact factor: 2.533

Review 9.  A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression.

Authors:  André Russowsky Brunoni; Mariana Lopes; Felipe Fregni
Journal:  Int J Neuropsychopharmacol       Date:  2008-08-28       Impact factor: 5.176

10.  Five-Factor Model personality profiles of drug users.

Authors:  Antonio Terracciano; Corinna E Löckenhoff; Rosa M Crum; O Joseph Bienvenu; Paul T Costa
Journal:  BMC Psychiatry       Date:  2008-04-11       Impact factor: 3.630

View more
  21 in total

1.  Genetics of serum BDNF: meta-analysis of the Val66Met and genome-wide association study.

Authors:  Antonio Terracciano; Maria Grazia Piras; Monia Lobina; Antonella Mulas; Osorio Meirelles; Angelina R Sutin; Wayne Chan; Serena Sanna; Manuela Uda; Laura Crisponi; David Schlessinger
Journal:  World J Biol Psychiatry       Date:  2011-11-02       Impact factor: 4.132

2.  Precursor ion exclusion for enhanced identification of plasma biomarkers.

Authors:  Wells W Wu; Rong-Fong Shen; Sung-Soo Park; Bronwen Martin; Stuart Maudsley
Journal:  Proteomics Clin Appl       Date:  2012-06       Impact factor: 3.494

3.  The BDNF Val66Met polymorphism modulates sleep intensity: EEG frequency- and state-specificity.

Authors:  Valérie Bachmann; Carina Klein; Sereina Bodenmann; Nikolaus Schäfer; Wolfgang Berger; Peter Brugger; Hans-Peter Landolt
Journal:  Sleep       Date:  2012-03-01       Impact factor: 5.849

4.  Neuroticism, depressive symptoms, and serum BDNF.

Authors:  Antonio Terracciano; Monia Lobina; Maria Grazia Piras; Antonella Mulas; Alessandra Cannas; Osorio Meirelles; Angelina R Sutin; Alan B Zonderman; Manuela Uda; Laura Crisponi; David Schlessinger
Journal:  Psychosom Med       Date:  2011-09-23       Impact factor: 4.312

5.  Effect of interaction between obesity-promoting genetic variants and behavioral factors on the risk of obese phenotypes.

Authors:  Sobia Rana; Ayesha Sultana; Adil Anwar Bhatti
Journal:  Mol Genet Genomics       Date:  2021-05-09       Impact factor: 3.291

6.  Val66Met BDNF polymorphism as a vulnerability factor for inflammation-associated depressive symptoms in women with breast cancer.

Authors:  Larissa N Dooley; Patricia A Ganz; Steve W Cole; Catherine M Crespi; Julienne E Bower
Journal:  J Affect Disord       Date:  2016-03-02       Impact factor: 4.839

7.  Associations Between Neurotransmitter Genes and Fatigue and Energy Levels in Women After Breast Cancer Surgery.

Authors:  Jasmine Eshragh; Anand Dhruva; Steven M Paul; Bruce A Cooper; Judy Mastick; Deborah Hamolsky; Jon D Levine; Christine Miaskowski; Kord M Kober
Journal:  J Pain Symptom Manage       Date:  2016-10-05       Impact factor: 3.612

8.  Neuroticism, extraversion, and motor function in community-dwelling older persons.

Authors:  Aron S Buchman; Patricia A Boyle; Robert S Wilson; Sue E Leurgans; Steven E Arnold; David A Bennett
Journal:  Am J Geriatr Psychiatry       Date:  2013-01-22       Impact factor: 4.105

9.  The Role of Neurotrophins in Major Depressive Disorder.

Authors:  Cheng Jiang; Stephen R Salton
Journal:  Transl Neurosci       Date:  2013-03-01       Impact factor: 1.757

10.  Brain-derived neurotrophic factor serum levels and genotype: association with depression during interferon-α treatment.

Authors:  Francis E Lotrich; Salwa Albusaysi; Robert E Ferrell
Journal:  Neuropsychopharmacology       Date:  2012-12-18       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.